Harvest Fund Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Sell |
33,839
-2,945
| -8% | -$206K | 0.11% | 131 |
|
|
2025
Q1 | $2.7M | Buy |
36,784
+2,514
| +7% | +$185K | 0.13% | 118 |
|
|
2024
Q4 | $2.25M | Buy |
34,270
+7,447
| +28% | +$488K | 0.1% | 132 |
|
|
2024
Q3 | $2.09M | Buy |
26,823
+9,203
| +52% | +$717K | 0.12% | 118 |
|
|
2024
Q2 | $1.37M | Buy |
17,620
+474
| +3% | +$37K | 0.1% | 125 |
|
|
2024
Q1 | $1.16M | Buy |
17,146
+12,029
| +235% | +$815K | 0.1% | 128 |
|
|
2023
Q4 | $343K | Buy |
5,117
+533
| +12% | +$35.7K | 0.05% | 152 |
|
|
2023
Q3 | $310K | Buy |
4,584
+1,496
| +48% | +$101K | 0.05% | 156 |
|
|
2023
Q2 | $221K | Buy |
3,088
+1,331
| +76% | +$95.3K | 0.04% | 183 |
|
|
2023
Q1 | $122K | Buy |
1,757
+106
| +6% | +$7.36K | 0.03% | 286 |
|
|
2022
Q4 | $112K | Buy |
1,651
+741
| +81% | +$50.3K | 0.03% | 315 |
|
|
2022
Q3 | $50K | Buy |
910
+844
| +1,279% | +$46.4K | 0.01% | 419 |
|
|
2022
Q2 | $4K | Hold |
66
| – | – | ﹤0.01% | 666 |
|
|
2022
Q1 | $4K | Hold |
66
| – | – | ﹤0.01% | 700 |
|
|
2021
Q4 | $3K | Hold |
66
| – | – | ﹤0.01% | 739 |
|
|
2021
Q3 | $3K | Buy |
+66
| New | +$3K | ﹤0.01% | 730 |
|
|
2020
Q3 | – | Sell |
-202
| Closed | -$10K | – | 531 |
|
|
2020
Q2 | $10K | Buy |
+202
| New | +$10K | ﹤0.01% | 442 |
|